Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases

[1]  K. Theil,et al.  Aberrant expression of CD19 as a marker of monocytic lineage in acute myelogenous leukemia. , 1997, American journal of clinical pathology.

[2]  D. Head,et al.  Revised classification of acute myeloid leukemia. , 1996, Leukemia.

[3]  T M Launder,et al.  Lymphoid-associated antigen expression by acute myeloid leukemia. , 1996, American journal of clinical pathology.

[4]  J. Rowley,et al.  AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. , 1995, Blood.

[5]  D C Ward,et al.  Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Matthews,et al.  Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group. , 1994, Blood.

[7]  J. Rowley,et al.  Detection of Fusion Transcripts Generated by the Inversion 16 Chromosome in Acute Myelogenous Leukemia , 1994 .

[8]  H. Dohy,et al.  Japanese B cell chronic lymphocytic leukaemia: a cytogenetic and molecular biological study , 1993, British journal of haematology.

[9]  R. Espinosa,et al.  Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. , 1993, Blood.

[10]  Y. C. Chen,et al.  Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML. , 1993, Leukemia.

[11]  E. Thiel,et al.  Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. , 1993, Leukemia.

[12]  F. Behm,et al.  Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. , 1992, Blood.

[13]  H. Drabkin,et al.  Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. , 1992, Blood.

[14]  T. Kyo,et al.  Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. , 1992, Blood.

[15]  E. Solary,et al.  Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL). , 1992, Leukemia.

[16]  H. Dohy,et al.  Diagnostic and clinical importance of interleukin‐2 receptor alpha chain expression on non‐T‐cell acute leukaemia cells , 1992, British journal of haematology.

[17]  M. Ohki,et al.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Freemont,et al.  Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. , 1991, Science.

[19]  J. Griffin,et al.  Prognostic value of lymphocyte surface markers in acute myeloid leukemia. , 1991, Blood.

[20]  N. Day,et al.  The delta TCS1 determinant is expressed on both disulfide- and non- disulfide-linked gamma delta T-cell antigen receptors [letter; comment] , 1991 .

[21]  N. Kamada,et al.  Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. , 1991, Blood.

[22]  B. Johansson,et al.  Geographic heterogeneity of neoplasia‐associated chromosome aberrations , 1991, Genes, chromosomes & cancer.

[23]  Christine Chomienne,et al.  The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus , 1990, Nature.

[24]  W G Hughes,et al.  Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations , 1989, British journal of haematology.

[25]  S. Tanabe,et al.  Involvement of bcl-2 gene in Japanese follicular lymphoma. , 1989, Blood.

[26]  Yao-chang Chen,et al.  Chromosome studies on 30 Chinese patients with acute nonlymphocytic leukemia in Taiwan. , 1988, Cancer genetics and cytogenetics.

[27]  Drexler Hg.  Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping. , 1987, Leukemia.

[28]  R. Ashmun,et al.  Expression of the human monocyte membrane antigen gp55 by murine fibroblasts after DNA-mediated gene transfer. , 1987, Blood.

[29]  F. Mitelman.  Geographic heterogeneity of chromosome aberrations in hematologic disorders. , 1986, Cancer genetics and cytogenetics.

[30]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[31]  M. Roussel,et al.  Transfer and expression of the gene encoding a human myeloid membrane antigen (gp150). , 1985, The Journal of clinical investigation.

[32]  C. Berard,et al.  Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States--Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. , 1983, Human pathology.

[33]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[34]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.

[35]  H. Drexler,et al.  Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping. , 1987, Leukemia.